510(k) Report

510(k) · Cleared

Cleared

Percusurge Guardwire Plus Temporary Occlusion and Aspiration System

K013913510(k) TraditionalCleared Nov 15, 2002353-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic Percusurge, Inc. · NFA Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection

Cleared on Nov 15, 2002 after a 353-day review. The FDA summary names its predicate without a number. 3 of the 75 devices in its family, counting itself, have a Class I recall. 74 later devices descend from it.

Decided
Nov 15, 2002
Review
353 days
Class
Class II
Product code
NFA
Recalls
None
Predicates
0

74 later devices descend from it, 6 citing it directly. 3 of the 75 devices in this family, counting this one, have a Class I recall.

Descendants, by year cleared 2005: 3 descendants cleared2006: 11 descendants cleared2008: 9 descendants cleared2003: 1 descendant cleared2007: 7 descendants cleared2004: 1 descendant cleared2009: 5 descendants cleared2012: 4 descendants cleared2013: 2 descendants cleared2011: 2 descendants cleared2015: 3 descendants cleared2018: 3 descendants cleared2017: 5 descendants cleared2014: 1 descendant cleared2023: 2 descendants cleared, 1 with a Class I recall12020: 4 descendants cleared2016: 3 descendants cleared, 1 with a Class I recall12010: 1 descendant cleared2026: 2 descendants cleared2025: 1 descendant cleared2019: 1 descendant cleared2021: 2 descendants cleared, 1 with a Class I recall12022: 1 descendant cleared200020052010201520202025
  1. This deviceK013913 Percusurge Guardwire Plus Temporary Occlusion and Aspiration SystemMedtronic Percusurge, Inc. · 2002
  2. Descendant · cites it directly · 60 of its ownK030201 Modification to Export Aspiration CatheterMedtronic Vascular · 2003
  3. Descendant · 2 generations on · 59 of its ownK040869 Export CatheterMedtronic Vascular · 2004
  4. Descendant · 3 generations on · 30 of its ownK061958 Medtronic Export XT CatheterMedtronic Vascular · 2006 · Recalled
  5. Descendant · 3 generations on · 16 of its ownK050130 Kerberos Proximal Solutions Rispiration SystemKerberos Proximal Solutions, Inc. · 2005
  6. Descendant · 3 generations on · 14 of its ownK050139 Modification to: Export CatheterMedtronic Vascular · 2005

Showing 5 of 74 descendants. See all descendants

Descendants cleared per year

2003: 12004: 12005: 32006: 112007: 72008: 92009: 52010: 12011: 22012: 42013: 22014: 12015: 32016: 32017: 52018: 32019: 12020: 42021: 22022: 12023: 22025: 12026: 2
2003high 11 (2006) · low 0 (2024)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 74 · See all
  • K030201Modification to Export Aspiration CatheterMedtronic Vascular · 2003 · cites it directly60descendants
  • K040869Export CatheterMedtronic Vascular · 2004 · 2 generations on59descendants
  • K061958Medtronic Export XT CatheterMedtronic Vascular · 2006 · 3 generations on30descendants
  • K050130Kerberos Proximal Solutions Rispiration SystemKerberos Proximal Solutions, Inc. · 2005 · 3 generations on16descendants
  • K050139Modification to: Export CatheterMedtronic Vascular · 2005 · 3 generations on14descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K013913Percusurge Guardwire Plus Temporary Occlusion and Aspiration SystemMedtronic Percusurge, Inc.2002—
+1K030201Modification to Export Aspiration CatheterMedtronic Vascular2003—
+2K040869Export CatheterMedtronic Vascular2004—
+3K061958Medtronic Export XT CatheterMedtronic Vascular20061
+3K050130Kerberos Proximal Solutions Rispiration SystemKerberos Proximal Solutions, Inc.2005—
+3K050139Modification to: Export CatheterMedtronic Vascular2005—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200410
200530
2006110
200770
200890
200950
201010
201120
201240
201320
201410
201530
201631
201750
201830
201910
202040
202121
202210
202321
202510
202620
FIG. 1 — Lineage of K013913, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

3 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—3-6 Guardwire Plus System
Named without a submission number
—

What descends from it? (74)

See all 74

6 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K030201Modification to Export Aspiration CatheterMedtronic Vascular200360
K051984Filterwire EZ (2.25 MM - 3.5 MM) Embolic Protection System, Models 20120-190, 20120-300Boston Scientific Corp20067
K042040Triactiv SystemKensey Nash Corp.20056
K060651Proxis System, Model EPS101St Jude Medical20063
K052523Proxis SystemVelocimed, Inc.20062
K073523Interceptor Plus Coronary Filter SystemsMedtronic, Inc.20080

Has anything in its family been recalled? (3 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K153485ENROUTE Transcarotid Neuroprotection SystemSilk Road Medical, Inc. · 2016 · 5 generations on · ◆ in the 2016 descendants bar of FIG. 11 Class I recall
  • K230402ENROUTE® Transcarotid Neuroprotection SystemSilk Road Medical · 2023 · 6 generations on · ◆ in the 2023 descendants bar of FIG. 11 Class I recall
  • K210282WIRION Embolic Protection SystemCardiovascular Systems, Inc. · 2021 · 7 generations on · ◆ in the 2021 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • Of its descendants, K030201 (Medtronic Vascular, 2003) has gone furthest, with 60 descendants of its own.

How does its category compare?

All NFA devices

NFA Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NFA

2in 2008

2007: 12008: 2
2007high 2 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NFA

Too few NFA 510(k)s in any year since 2007 to give a median.

Recalls per year · NFA

No recall names NFA since 2007.

Adverse event reports per year · NFA

91in 2025

2007: 1102008: 802009: 1042010: 1832011: 452012: 552013: 482014: 422015: 412016: 632017: 502018: 782019: 402020: 202021: 252022: 232023: 222024: 552025: 91
2007high 183 (2010) · low 20 (2020)2025

MAUDE reports naming product code NFA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—0110
20082—080
20090—0104
20100—0183
20110—045
20120—055
20130—048
20140—042
20150—041
20160—063
20170—050
20180—078
20190—040
20200—020
20210—025
20220—023
20230—022
20240—055
20250—091
20260—0—

What is it indicated for?

The PercuSurge Guardwire Plus Temporary Occlusion & Aspiration System is indicated for use in the coronary saphenous vein bypass grafts (2.5-5.Omm) to: Contain and aspirate embolic material (thrombusldebris) while performing percutaneous transluminal coronary angioplasty or stenting procedures. To subselectively infuse/deliver diagnostic or therapeutic agents with or without vessel occlusion. The safety and effectiveness of the device as an embolic…

Read the full statement (115 words)

The PercuSurge Guardwire Plus Temporary Occlusion & Aspiration System is indicated for use in the coronary saphenous vein bypass grafts (2.5-5.Omm) to:

Contain and aspirate embolic material (thrombusldebris) while performing percutaneous transluminal coronary angioplasty or stenting procedures.

To subselectively infuse/deliver diagnostic or therapeutic agents with or without vessel occlusion.

The safety and effectiveness of the device as an embolic protection system has not been established in the cerebral, carotid or peripheral vasculature.

The safety and effectiveness of the device as an embolic protection system has not been established in treating patients with acute myocardial infarction.

The safety and effectiveness of the device as an embolic protection system has not been established in treating native coronaries.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K013913: Percusurge Guardwire Plus Temporary Occlusion and Aspiration System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K013913

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026